{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:03:36Z","timestamp":1790388216506,"version":"4.1.0"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,2,27]],"date-time":"2011-02-27T00:00:00Z","timestamp":1298764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s10552-011-9745-4","type":"journal-article","created":{"date-parts":[[2011,2,26]],"date-time":"2011-02-26T10:07:25Z","timestamp":1298714845000},"page":"785-801","source":"Crossref","is-referenced-by-count":29,"title":["Genomics of the NF-\u03baB signaling pathway: hypothesized role in ovarian cancer"],"prefix":"10.1007","volume":"22","author":[{"given":"Kristin L.","family":"White","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly R.","family":"Kalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith L.","family":"Knutson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail P.","family":"Jarvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen L.","family":"Goode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,2,27]]},"reference":[{"issue":"5","key":"9745_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","volume":"60","author":"A Jemal","year":"2010","unstructured":"Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 60(5):277\u2013300","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"9745_CR2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0090-8258(92)90100-W","volume":"47","author":"WJ Hoskins","year":"1992","unstructured":"Hoskins WJ, Bundy BN, Thigpen JT, Omura GA (1992) The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol 47(2):159\u2013166","journal-title":"Gynecol Oncol"},{"issue":"3","key":"9745_CR3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1006\/gyno.2001.6536","volume":"84","author":"V McGuire","year":"2002","unstructured":"McGuire V, Jesser CA, Whittemore AS (2002) Survival among U.S. women with invasive epithelial ovarian cancer. Gynecol Oncol 84(3):399\u2013403","journal-title":"Gynecol Oncol"},{"issue":"4","key":"9745_CR4","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1067\/S0002-9378(03)00579-9","volume":"189","author":"JS Barnholtz-Sloan","year":"2003","unstructured":"Barnholtz-Sloan JS, Schwartz AG, Qureshi F, Jacques S, Malone J, Munkarah AR (2003) Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. Am J Obstet Gynecol 189(4):1120\u20131127","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"9745_CR5","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","volume":"164","author":"M Shih Ie","year":"2004","unstructured":"Shih Ie M, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164(5):1511\u20131518","journal-title":"Am J Pathol"},{"issue":"12","key":"9745_CR6","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1470-2045(08)70308-5","volume":"9","author":"L Dubeau","year":"2008","unstructured":"Dubeau L (2008) The cell of origin of ovarian epithelial tumours. Lancet Oncol 9(12):1191\u20131197","journal-title":"Lancet Oncol"},{"issue":"3","key":"9745_CR7","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","volume":"34","author":"RJ Kurman","year":"2010","unstructured":"Kurman RJ, Shih Ie M (2010) The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34(3):433\u2013443","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"9745_CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00006254-197203000-00001","volume":"27","author":"SC Lauchlan","year":"1972","unstructured":"Lauchlan SC (1972) The secondary Mullerian system. Obstet Gynecol Surv 27(3):133\u2013146","journal-title":"Obstet Gynecol Surv"},{"key":"9745_CR9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","volume":"4","author":"KR Cho","year":"2009","unstructured":"Cho KR, Shih Ie M (2009) Ovarian cancer. Annu Rev Pathol 4:287\u2013313","journal-title":"Annu Rev Pathol"},{"issue":"7716","key":"9745_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","volume":"2","author":"MF Fathalla","year":"1971","unstructured":"Fathalla MF (1971) Incessant ovulation\u2013a factor in ovarian neoplasia? Lancet 2(7716):163","journal-title":"Lancet"},{"issue":"2","key":"9745_CR11","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1095\/biolreprod54.2.436","volume":"54","author":"N Bonello","year":"1996","unstructured":"Bonello N, McKie K, Jasper M, Andrew L, Ross N, Braybon E et al (1996) Inhibition of nitric oxide: effects on interleukin-1 beta-enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at ovulation in the rat. Biol Reprod 54(2):436\u2013445","journal-title":"Biol Reprod"},{"issue":"12","key":"9745_CR12","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1093\/oxfordjournals.humrep.a019189","volume":"11","author":"U Zackrisson","year":"1996","unstructured":"Zackrisson U, Mikuni M, Wallin A, Delbro D, Hedin L, Brannstrom M (1996) Cell-specific localization of nitric oxide synthases (NOS) in the rat ovary during follicular development, ovulation and luteal formation. Hum Reprod 11(12):2667\u20132673","journal-title":"Hum Reprod"},{"issue":"13","key":"9745_CR13","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/jnci\/89.13.932","volume":"89","author":"JM Schildkraut","year":"1997","unstructured":"Schildkraut JM, Bastos E, Berchuck A (1997) Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer. J Natl Cancer Inst 89(13):932\u2013938","journal-title":"J Natl Cancer Inst"},{"issue":"1\u20132","key":"9745_CR14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2005.09.014","volume":"247","author":"JS Fleming","year":"2006","unstructured":"Fleming JS, Beaugie CR, Haviv I, Chenevix-Trench G, Tan OL (2006) Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol 247(1\u20132):4\u201321","journal-title":"Mol Cell Endocrinol"},{"issue":"4","key":"9745_CR15","doi-asserted-by":"crossref","first-page":"e10358","DOI":"10.1371\/journal.pone.0010358","volume":"5","author":"B Pothuri","year":"2010","unstructured":"Pothuri B, Leitao MM, Levine DA, Viale AS, Olshen AB, Arroyo C et al (2010) Genetic analysis of the early natural history of epithelial ovarian carcinoma. PLoS ONE 5(4):e10358","journal-title":"PLoS ONE"},{"issue":"49","key":"9745_CR16","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","volume":"18","author":"HL Pahl","year":"1999","unstructured":"Pahl HL (1999) Activators and target genes of Rel\/NF-kappaB transcription factors. Oncogene 18(49):6853\u20136866","journal-title":"Oncogene"},{"issue":"12","key":"9745_CR17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.molmed.2003.10.007","volume":"9","author":"O Kutuk","year":"2003","unstructured":"Kutuk O, Basaga H (2003) Inflammation meets oxidation: NF-kappaB as a mediator of initial lesion development in atherosclerosis. Trends Mol Med 9(12):549\u2013557","journal-title":"Trends Mol Med"},{"issue":"18","key":"9745_CR18","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","volume":"18","author":"MS Hayden","year":"2004","unstructured":"Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18(18):2195\u20132224","journal-title":"Genes Dev"},{"issue":"51","key":"9745_CR19","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1038\/sj.onc.1209939","volume":"25","author":"G Courtois","year":"2006","unstructured":"Courtois G, Gilmore TD (2006) Mutations in the NF-kappaB signaling pathway: implications for human disease. Oncogene 25(51):6831\u20136843","journal-title":"Oncogene"},{"issue":"3","key":"9745_CR20","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11883-005-0005-5","volume":"7","author":"F Cambien","year":"2005","unstructured":"Cambien F (2005) Coronary heart disease and polymorphisms in genes affecting lipid metabolism and inflammation. Curr Atheroscler Rep 7(3):188\u2013195","journal-title":"Curr Atheroscler Rep"},{"issue":"1","key":"9745_CR21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5483\/BMBRep.2002.35.1.028","volume":"35","author":"S Shishodia","year":"2002","unstructured":"Shishodia S, Aggarwal BB (2002) Nuclear factor-kappaB activation: a question of life or death. J Biochem Mol Biol 35(1):28\u201340","journal-title":"J Biochem Mol Biol"},{"issue":"1","key":"9745_CR22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3181\/0707-MR-196","volume":"233","author":"G Sethi","year":"2008","unstructured":"Sethi G, Sung B, Aggarwal BB (2008) Nuclear factor-kappaB activation: from bench to bedside. Exp Biol Med (Maywood) 233(1):21\u201331","journal-title":"Exp Biol Med (Maywood)"},{"issue":"49","key":"9745_CR23","doi-asserted-by":"crossref","first-page":"6925","DOI":"10.1038\/sj.onc.1203222","volume":"18","author":"TD Gilmore","year":"1999","unstructured":"Gilmore TD (1999) Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel. Oncogene 18(49):6925\u20136937","journal-title":"Oncogene"},{"issue":"7092","key":"9745_CR24","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","volume":"441","author":"M Karin","year":"2006","unstructured":"Karin M (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441(7092):431\u2013436","journal-title":"Nature"},{"issue":"10","key":"9745_CR25","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/jnci\/95.10.733","volume":"95","author":"YL Hu","year":"2003","unstructured":"Hu YL, Albanese C, Pestell RG, Jaffe RB (2003) Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells. J Natl Cancer Inst 95(10):733\u2013740","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"9745_CR26","doi-asserted-by":"crossref","first-page":"23477","DOI":"10.1074\/jbc.M313709200","volume":"279","author":"S Mabuchi","year":"2004","unstructured":"Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T et al (2004) Inhibition of NFkappaB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models. J Biol Chem 279(22):23477\u201323485","journal-title":"J Biol Chem"},{"issue":"22","key":"9745_CR27","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1158\/1078-0432.CCR-04-0958","volume":"10","author":"S Mabuchi","year":"2004","unstructured":"Mabuchi S, Ohmichi M, Nishio Y, Hayasaka T, Kimura A, Ohta T et al (2004) Inhibition of inhibitor of nuclear factor-kappaB phosphorylation increases the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models. Clin Cancer Res 10(22):7645\u20137654","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9745_CR28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/en.2001-211024","volume":"144","author":"CW Xiao","year":"2003","unstructured":"Xiao CW, Yan X, Li Y, Reddy SA, Tsang BK (2003) Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein. Endocrinology 144(2):623\u2013630","journal-title":"Endocrinology"},{"key":"9745_CR29","first-page":"5334","volume":"60","author":"S Huang","year":"2000","unstructured":"Huang S, Robinson JB, DeGuzman A, Bucana CD, Fidler IJ (2000) Blockade of Nuclear Factor-kB Signaling Inhibits Angiogenesis and Tumorigenicity of Human Ovarian Cancer Cells by Suppressing Expression of Vascular Endothelial Growth Factor and Interleukin 81. Cancer Res 60:5334\u20135339","journal-title":"Cancer Res"},{"issue":"10","key":"9745_CR30","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1158\/0008-5472.CAN-09-3912","volume":"70","author":"L Hernandez","year":"2010","unstructured":"Hernandez L, Hsu SC, Davidson B, Birrer MJ, Kohn EC, Annunziata CM (2010) Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer. Cancer Res 70(10):4005\u20134014","journal-title":"Cancer Res"},{"issue":"1","key":"9745_CR31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/cc.8.1.7533","volume":"8","author":"AB Alvero","year":"2009","unstructured":"Alvero AB, Chen R, Fu H, Montagna M, Schwartz PE, Rutherford T et al (2009) Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle 8(1):158\u2013166","journal-title":"Cell Cycle"},{"issue":"24","key":"9745_CR32","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1038\/onc.2010.111","volume":"29","author":"G Yin","year":"2010","unstructured":"Yin G, Chen R, Alvero AB, Fu HH, Holmberg J, Glackin C et al (2010) TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2\/214. Oncogene 29(24):3545\u20133553","journal-title":"Oncogene"},{"issue":"7","key":"9745_CR33","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00262-010-0836-y","volume":"59","author":"T Zhang","year":"2010","unstructured":"Zhang T, Ma Z, Wang R, Wang Y, Wang S, Cheng Z et al (2010) Thrombin facilitates invasion of ovarian cancer along peritoneum by inducing monocyte differentiation toward tumor-associated macrophage-like cells. Cancer Immunol Immunother 59(7):1097\u20131108","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"9745_CR34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G et al (2003) Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 348(3):203\u2013213","journal-title":"N Engl J Med"},{"issue":"4","key":"9745_CR35","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000058060","volume":"51","author":"AD Santin","year":"2001","unstructured":"Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman JJ, Smith CV et al (2001) Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer. Gynecol Obstet Invest 51(4):254\u2013261","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"9745_CR36","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nm863","volume":"9","author":"TJ Curiel","year":"2003","unstructured":"Curiel TJ, Wei S, Dong H, Alvarez X, Cheng P, Mottram P et al (2003) Blockade of B7\u2013H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 9(5):562\u2013567","journal-title":"Nat Med"},{"issue":"5","key":"9745_CR37","first-page":"1723","volume":"150","author":"RP Negus","year":"1997","unstructured":"Negus RP, Stamp GW, Hadley J, Balkwill FR (1997) Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am J Pathol 150(5):1723\u20131734","journal-title":"Am J Pathol"},{"issue":"9","key":"9745_CR38","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10(9):942\u2013949","journal-title":"Nat Med"},{"issue":"51","key":"9745_CR39","doi-asserted-by":"crossref","first-page":"18538","DOI":"10.1073\/pnas.0509182102","volume":"102","author":"E Sato","year":"2005","unstructured":"Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F et al (2005) Intraepithelial CD8\u00a0+\u00a0tumor-infiltrating lymphocytes and a high CD8\u00a0+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 102(51):18538\u201318543","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"9745_CR40","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1146\/annurev.immunol.22.012703.104622","volume":"22","author":"S Pestka","year":"2004","unstructured":"Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22(1):929\u2013979","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"9745_CR41","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.4049\/jimmunol.156.6.2119","volume":"156","author":"MF Romano","year":"1996","unstructured":"Romano MF, Lamberti A, Petrella A, Bisogni R, Tassone PF, Formisano S et al (1996) IL-10 inhibits nuclear factor-kappa B\/Rel nuclear activity in CD3- stimulated human peripheral T lymphocytes. J Immunol 156(6):2119\u20132123","journal-title":"J Immunol"},{"issue":"17","key":"9745_CR42","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1073\/pnas.1003345107","volume":"107","author":"J Matsuzaki","year":"2010","unstructured":"Matsuzaki J, Gnjatic S, Mhawech-Fauceglia P, Beck A, Miller A, Tsuji T et al (2010) Tumor-infiltrating NY-ESO-1-specific CD8\u00a0+\u00a0T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc Natl Acad Sci USA 107(17):7875\u20137880","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"9745_CR43","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.it.2005.04.003","volume":"26","author":"Q Li","year":"2005","unstructured":"Li Q, Withoff S, Verma IM (2005) Inflammation-associated cancer: NF-kappaB is the lynchpin. Trends Immunol 26(6):318\u2013325","journal-title":"Trends Immunol"},{"issue":"1","key":"9745_CR44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/biof.5520290103","volume":"29","author":"CH Lee","year":"2007","unstructured":"Lee CH, Jeon YT, Kim SH, Song YS (2007) NF-kappaB as a potential molecular target for cancer therapy. Biofactors 29(1):19\u201335","journal-title":"Biofactors"},{"issue":"7","key":"9745_CR45","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2174\/156652407782564363","volume":"7","author":"KS Ahn","year":"2007","unstructured":"Ahn KS, Sethi G, Aggarwal BB (2007) Nuclear factor-kappa B: from clone to clinic. Curr Mol Med 7(7):619\u2013637","journal-title":"Curr Mol Med"},{"issue":"8","key":"9745_CR46","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/bies.10306","volume":"25","author":"HC Liou","year":"2003","unstructured":"Liou HC, Hsia CY (2003) Distinctions between c-Rel and other NF-kappaB proteins in immunity and disease. Bioessays 25(8):767\u2013780","journal-title":"Bioessays"},{"issue":"6","key":"9745_CR47","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.it.2004.03.008","volume":"25","author":"G Bonizzi","year":"2004","unstructured":"Bonizzi G, Karin M (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25(6):280\u2013288","journal-title":"Trends Immunol"},{"issue":"3","key":"9745_CR48","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2249.2005.02801.x","volume":"140","author":"PA Hopkins","year":"2005","unstructured":"Hopkins PA, Sriskandan S (2005) Mammalian Toll-like receptors: to immunity and beyond. Clin Exp Immunol 140(3):395\u2013407","journal-title":"Clin Exp Immunol"},{"issue":"5534","key":"9745_CR49","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1126\/science.1062677","volume":"293","author":"U Senftleben","year":"2001","unstructured":"Senftleben U, Cao Y, Xiao G, Greten FR, Krahn G, Bonizzi G et al (2001) Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293(5534):1495\u20131499","journal-title":"Science"},{"issue":"3","key":"9745_CR50","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1349-7006.2007.00389.x","volume":"98","author":"J Inoue","year":"2007","unstructured":"Inoue J, Gohda J, Akiyama T, Semba K (2007) NF-kappaB activation in development and progression of cancer. Cancer Sci 98(3):268\u2013274","journal-title":"Cancer Sci"},{"issue":"4","key":"9745_CR51","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4049\/jimmunol.167.4.1909","volume":"167","author":"DS Weih","year":"2001","unstructured":"Weih DS, Yilmaz ZB, Weih F (2001) Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J Immunol 167(4):1909\u20131919","journal-title":"J Immunol"},{"issue":"2","key":"9745_CR52","first-page":"195","volume":"64","author":"MS Piver","year":"1984","unstructured":"Piver MS, Mettlin CJ, Tsukada Y, Nasca P, Greenwald P, McPhee ME (1984) Familial ovarian cancer registry. Obstet Gynecol 64(2):195\u2013199","journal-title":"Obstet Gynecol"},{"issue":"8","key":"9745_CR53","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/aje\/kwh103","volume":"159","author":"KH Tung","year":"2004","unstructured":"Tung KH, Goodman MT, Wu AH, McDuffie K, Wilkens LR, Nomura AM et al (2004) Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives. Am J Epidemiol 159(8):750\u2013758","journal-title":"Am J Epidemiol"},{"issue":"2","key":"9745_CR54","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2217\/14796694.2.2.257","volume":"2","author":"AC Antoniou","year":"2006","unstructured":"Antoniou AC, Easton DF (2006) Risk prediction models for familial breast cancer. Future Oncol 2(2):257\u2013274","journal-title":"Future Oncol"},{"issue":"5","key":"9745_CR55","first-page":"1013","volume":"60","author":"CI Szabo","year":"1997","unstructured":"Szabo CI, King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60(5):1013\u20131020","journal-title":"Am J Hum Genet"},{"key":"9745_CR56","doi-asserted-by":"crossref","unstructured":"Lindor NM, McMaster ML, Lindor CJ, Greene MH (2008) Concise handbook of familial cancer susceptibility syndromes\u2014second edition. J Natl Cancer Inst Monogr (38):1\u201393","DOI":"10.1093\/jncimonographs\/lgn001"},{"issue":"2","key":"9745_CR57","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molonc.2009.01.008","volume":"3","author":"PA Fasching","year":"2009","unstructured":"Fasching PA, Gayther S, Pearce L, Schildkraut JM, Goode E, Thiel F et al (2009) Role of genetic polymorphisms and ovarian cancer susceptibility. Molecular Oncology 3(2):171\u2013181","journal-title":"Molecular Oncology"},{"issue":"5281","key":"9745_CR58","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1126\/science.273.5281.1516","volume":"273","author":"N Risch","year":"1996","unstructured":"Risch N, Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273(5281):1516\u20131517","journal-title":"Science"},{"issue":"1","key":"9745_CR59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ng853","volume":"31","author":"PD Pharoah","year":"2002","unstructured":"Pharoah PD, Antoniou A, Bobrow M, Zimmern RL, Easton DF, Ponder BA (2002) Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 31(1):33\u201336","journal-title":"Nat Genet"},{"issue":"2","key":"9745_CR60","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.23448","volume":"123","author":"SJ Ramus","year":"2008","unstructured":"Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH et al (2008) Consortium analysis of 7 candidate SNPs for ovarian cancer. Intl J Cancer 123(2):380\u2013388","journal-title":"Intl J Cancer"},{"issue":"2","key":"9745_CR61","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/sj.bjc.6604820","volume":"100","author":"CL Pearce","year":"2009","unstructured":"Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U et al (2009) Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. Br J Cancer 100(2):412\u2013420","journal-title":"Br J Cancer"},{"issue":"20","key":"9745_CR62","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1001\/jama.299.20.2423","volume":"299","author":"LM Dong","year":"2008","unstructured":"Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, Peters U (2008) Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. Jama 299(20):2423\u20132436","journal-title":"Jama"},{"issue":"7148","key":"9745_CR63","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/nature05887","volume":"447","author":"DF Easton","year":"2007","unstructured":"Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148):1087\u20131093","journal-title":"Nature"},{"issue":"8","key":"9745_CR64","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/ng2085","volume":"39","author":"I Tomlinson","year":"2007","unstructured":"Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S et al (2007) A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39(8):984\u2013988","journal-title":"Nat Genet"},{"issue":"9","key":"9745_CR65","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.424","volume":"41","author":"H Song","year":"2009","unstructured":"Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E et al (2009) A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 41(9):996\u20131000","journal-title":"Nat Genet"},{"issue":"10","key":"9745_CR66","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ng.668","volume":"42","author":"EL Goode","year":"2010","unstructured":"Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K et al (2010) A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet 42(10):874\u2013879","journal-title":"Nat Genet"},{"issue":"10","key":"9745_CR67","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ng.666","volume":"42","author":"KL Bolton","year":"2010","unstructured":"Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C et al (2010) Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 42(10):880\u2013884","journal-title":"Nat Genet"},{"issue":"7","key":"9745_CR68","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1158\/0008-5472.CAN-06-3261","volume":"67","author":"SA Gayther","year":"2007","unstructured":"Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L et al (2007) Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res 67(7):3027\u20133035","journal-title":"Cancer Res"},{"issue":"2","key":"9745_CR69","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/sj.bjc.6604170","volume":"98","author":"CL Pearce","year":"2008","unstructured":"Pearce CL, Wu AH, Gayther SA, Bale AE, Beck PA, Beesley J et al (2008) Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis. Br J Cancer 98(2):282\u2013288","journal-title":"Br J Cancer"},{"issue":"6","key":"9745_CR70","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1158\/0008-5472.CAN-08-2902","volume":"69","author":"JM Schildkraut","year":"2009","unstructured":"Schildkraut JM, Goode EL, Clyde MA, Iversen ES, Moorman PG, Berchuck A et al (2009) Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res 69(6):2349\u20132357","journal-title":"Cancer Res"},{"issue":"7","key":"9745_CR71","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1158\/0008-5472.CAN-07-5165","volume":"68","author":"LE Kelemen","year":"2008","unstructured":"Kelemen LE, Sellers TA, Schildkraut JM, Cunningham JM, Vierkant RA, Pankratz VS et al (2008) Genetic variation in the one-carbon transfer pathway and ovarian cancer risk. Cancer Res 68(7):2498\u20132506","journal-title":"Cancer Res"},{"issue":"3","key":"9745_CR72","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1078-0432.CCR-09-2553","volume":"16","author":"EL Goode","year":"2010","unstructured":"Goode EL, Maurer MJ, Sellers TA, Phelan CM, Kalli KR, Fridley BL et al (2010) Inherited determinants of ovarian cancer survival. Clin Cancer Res 16(3):995\u20131007","journal-title":"Clin Cancer Res"},{"issue":"2","key":"9745_CR73","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1200\/JCO.2005.05.122","volume":"23","author":"MR Spitz","year":"2005","unstructured":"Spitz MR, Wu X, Mills G (2005) Integrative epidemiology: from risk assessment to outcome prediction. J Clin Oncol 23(2):267\u2013275","journal-title":"J Clin Oncol"},{"issue":"18","key":"9745_CR74","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1158\/1078-0432.CCR-08-0819","volume":"14","author":"L Quaye","year":"2008","unstructured":"Quaye L, Gayther SA, Ramus SJ, Di Cioccio RA, McGuire V, Hogdall E et al (2008) The effects of common genetic variants in oncogenes on ovarian cancer survival. Clin Cancer Res 14(18):5833\u20135839","journal-title":"Clin Cancer Res"},{"issue":"22","key":"9745_CR75","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1158\/1078-0432.CCR-08-0351","volume":"14","author":"AM Schultheis","year":"2008","unstructured":"Schultheis AM, Lurje G, Rhodes KE, Zhang W, Yang D, Garcia AA et al (2008) Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab. Clin Cancer Res 14(22):7554\u20137563","journal-title":"Clin Cancer Res"},{"issue":"8","key":"9745_CR76","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/aje\/kwj269","volume":"164","author":"P Bhatti","year":"2006","unstructured":"Bhatti P, Church DM, Rutter JL, Struewing JP, Sigurdson AJ (2006) Candidate single nucleotide polymorphism selection using publicly available tools: a guide for epidemiologists. Am J Epidemiol 164(8):794\u2013804","journal-title":"Am J Epidemiol"},{"issue":"7063","key":"9745_CR77","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nature04226","volume":"437","author":"International HapMap Consortium","year":"2005","unstructured":"International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437(7063):1299\u20131320","journal-title":"Nature"},{"key":"9745_CR78","doi-asserted-by":"crossref","unstructured":"The 1000 Genomes Project Consortium (2010) A map of human genome variation from population-scale sequencing. Nature 467(7319):1061\u20131073","DOI":"10.1038\/nature09534"},{"issue":"5576","key":"9745_CR79","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1126\/science.1069424","volume":"296","author":"SB Gabriel","year":"2002","unstructured":"Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al (2002) The structure of haplotype blocks in the human genome. Science 296(5576):2225\u20132229","journal-title":"Science"},{"issue":"2","key":"9745_CR80","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng1001-229","volume":"29","author":"MJ Daly","year":"2001","unstructured":"Daly MJ, Rioux JD, Schaffner SF, Hudson TJ, Lander ES (2001) High-resolution haplotype structure in the human genome. Nat Genet 29(2):229\u2013232","journal-title":"Nat Genet"},{"issue":"5530","key":"9745_CR81","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1126\/science.293.5530.583b","volume":"293","author":"L Helmuth","year":"2001","unstructured":"Helmuth L (2001) Genome research: map of the human genome 3.0. Science 293(5530):583\u2013585","journal-title":"Science"},{"issue":"5547","key":"9745_CR82","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1126\/science.1065573","volume":"294","author":"N Patil","year":"2001","unstructured":"Patil N, Berno AJ, Hinds DA, Barrett WA, Doshi JM, Hacker CR et al (2001) Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21. Science 294(5547):1719\u20131723","journal-title":"Science"},{"issue":"6","key":"9745_CR83","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(01)00599-2","volume":"107","author":"Y Cao","year":"2001","unstructured":"Cao Y, Bonizzi G, Seagroves TN, Greten FR, Johnson R, Schmidt EV et al (2001) IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell 107(6):763\u2013775","journal-title":"Cell"},{"issue":"1","key":"9745_CR84","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1517\/14622416.2.1.11","volume":"2","author":"JS Bader","year":"2001","unstructured":"Bader JS (2001) The relative power of SNPs and haplotype as genetic markers for association tests. Pharmacogenomics 2(1):11\u201324","journal-title":"Pharmacogenomics"},{"issue":"3","key":"9745_CR85","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/gepi.10200","volume":"23","author":"RW Morris","year":"2002","unstructured":"Morris RW, Kaplan NL (2002) On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet Epidemiol 23(3):221\u2013233","journal-title":"Genet Epidemiol"},{"issue":"2","key":"9745_CR86","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/ng1001-233","volume":"29","author":"GC Johnson","year":"2001","unstructured":"Johnson GC, Esposito L, Barratt BJ, Smith AN, Heward J, Di Genova G et al (2001) Haplotype tagging for the identification of common disease genes. Nat Genet 29(2):233\u2013237","journal-title":"Nat Genet"},{"issue":"1","key":"9745_CR87","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1086\/381000","volume":"74","author":"CS Carlson","year":"2004","unstructured":"Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74(1):106\u2013120","journal-title":"Am J Hum Genet"},{"issue":"19","key":"9745_CR88","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1007\/s00018-008-8064-8","volume":"65","author":"L Verstrepen","year":"2008","unstructured":"Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A, Beyaert R (2008) TLR-4, IL-1R and TNF-R signaling to NF-kappaB: variations on a common theme. Cell Mol Life Sci 65(19):2964\u20132978","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"9745_CR89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cyto.2007.09.016","volume":"41","author":"H Li","year":"2008","unstructured":"Li H, Lin X (2008) Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation. Cytokine 41(1):1\u20138","journal-title":"Cytokine"},{"issue":"8","key":"9745_CR90","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1073\/pnas.0500187102","volume":"102","author":"J Hauer","year":"2005","unstructured":"Hauer J, Puschner S, Ramakrishnan P, Simon U, Bongers M, Federle C et al (2005) TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2\/5-mediated activation of the noncanonical NF-{kappa}B pathway by TRAF-binding TNFRs. Proc Natl Acad Sci USA 102(8):2874\u20132879","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"9745_CR91","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1074-7613(02)00423-5","volume":"17","author":"E Dejardin","year":"2002","unstructured":"Dejardin E, Droin NM, Delhase M, Haas E, Cao Y, Makris C et al (2002) The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17(4):525\u2013535","journal-title":"Immunity"},{"issue":"7","key":"9745_CR92","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1074\/jbc.M308062200","volume":"279","author":"AC Bharti","year":"2004","unstructured":"Bharti AC, Takada Y, Shishodia S, Aggarwal BB (2004) Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism. J Biol Chem 279(7):6065\u20136076","journal-title":"J Biol Chem"},{"key":"9745_CR93","volume-title":"The cell: a molecular approach","author":"GM Cooper","year":"2007","unstructured":"Cooper GM, Hausman RE (2007) The cell: a molecular approach, 4th edn. Sinauer Associates, Inc., Sunderlander","edition":"4"},{"issue":"4","key":"9745_CR94","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cytogfr.2006.04.005","volume":"17","author":"G Xiao","year":"2006","unstructured":"Xiao G, Rabson AB, Young W, Qing G, Qu Z (2006) Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease. Cytokine Growth Factor Rev 17(4):281\u2013293","journal-title":"Cytokine Growth Factor Rev"},{"issue":"11","key":"9745_CR95","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1084\/jem.189.11.1839","volume":"189","author":"ZW Li","year":"1999","unstructured":"Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M et al (1999) The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med 189(11):1839\u20131845","journal-title":"J Exp Med"},{"issue":"2","key":"9745_CR96","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.molcel.2006.03.026","volume":"22","author":"CK Ea","year":"2006","unstructured":"Ea CK, Deng L, Xia ZP, Pineda G, Chen ZJ (2006) Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22(2):245\u2013257","journal-title":"Mol Cell"},{"issue":"23","key":"9745_CR97","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1093\/hmg\/ddi405","volume":"14","author":"A Morlon","year":"2005","unstructured":"Morlon A, Munnich A, Smahi A (2005) TAB 2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd. Hum Mol Genet 14(23):3751\u20133757","journal-title":"Hum Mol Genet"},{"issue":"1","key":"9745_CR98","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/emboj\/18.1.179","volume":"18","author":"K Yamaguchi","year":"1999","unstructured":"Yamaguchi K, Nagai S, Ninomiya-Tsuji J, Nishita M, Tamai K, Irie K et al (1999) XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB 1-TAK1 in the BMP signaling pathway. EMBO J 18(1):179\u2013187","journal-title":"EMBO J"},{"issue":"2","key":"9745_CR99","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0092-8674(00)80984-8","volume":"84","author":"H Hsu","year":"1996","unstructured":"Hsu H, Shu HB, Pan MG, Goeddel DV (1996) TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84(2):299\u2013308","journal-title":"Cell"},{"issue":"10","key":"9745_CR100","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1172\/JCI26471","volume":"115","author":"HM Beere","year":"2005","unstructured":"Beere HM (2005) Death versus survival: functional interaction between the apoptotic and stress-inducible heat shock protein pathways. J Clin Invest 115(10):2633\u20132639","journal-title":"J Clin Invest"},{"issue":"39","key":"9745_CR101","doi-asserted-by":"crossref","first-page":"36530","DOI":"10.1074\/jbc.M104837200","volume":"276","author":"K Tada","year":"2001","unstructured":"Tada K, Okazaki T, Sakon S, Kobarai T, Kurosawa K, Yamaoka S et al (2001) Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death. J Biol Chem 276(39):36530\u201336534","journal-title":"J Biol Chem"},{"issue":"7","key":"9745_CR102","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/89769","volume":"2","author":"J Yang","year":"2001","unstructured":"Yang J, Lin Y, Guo Z, Cheng J, Huang J, Deng L et al (2001) The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol 2(7):620\u2013624","journal-title":"Nat Immunol"},{"issue":"24","key":"9745_CR103","doi-asserted-by":"crossref","first-page":"10757","DOI":"10.1128\/MCB.24.24.10757-10765.2004","volume":"24","author":"M Blonska","year":"2004","unstructured":"Blonska M, You Y, Geleziunas R, Lin X (2004) Restoration of NF-kappaB activation by tumor necrosis factor alpha receptor complex-targeted MEKK3 in receptor-interacting protein-deficient cells. Mol Cell Biol 24(24):10757\u201310765","journal-title":"Mol Cell Biol"},{"issue":"27","key":"9745_CR104","doi-asserted-by":"crossref","first-page":"8260","DOI":"10.1021\/bi034013b","volume":"42","author":"M Ouellet","year":"2003","unstructured":"Ouellet M, Roy J, Barbeau B, Geleziunas R, Tremblay MJ (2003) NF-kappaB induction by bisperoxovanadium compounds requires CD45, p36(LAT), PKC, and IKK activity and exhibits kinetics of activation comparable to those of TCR\/CD28 coengagement. Biochemistry 42(27):8260\u20138271","journal-title":"Biochemistry"},{"issue":"5","key":"9745_CR105","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1046\/j.1432-1327.2001.02028.x","volume":"268","author":"A Livolsi","year":"2001","unstructured":"Livolsi A, Busuttil V, Imbert V, Abraham RT (2001) Peyron JF (2001) Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases. Eur J Biochem 268(5):1508\u20131515","journal-title":"Eur J Biochem"},{"issue":"1","key":"9745_CR106","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4049\/jimmunol.170.1.365","volume":"170","author":"O Dienz","year":"2003","unstructured":"Dienz O, Moller A, Strecker A, Stephan N, Krammer PH, Droge W et al (2003) Src homology 2 domain-containing leukocyte phosphoprotein of 76\u00a0kDa and phospholipase C gamma 1 are required for NF-kappa B activation and lipid raft recruitment of protein kinase C theta induced by T cell costimulation. J Immunol 170(1):365\u2013372","journal-title":"J Immunol"},{"issue":"1","key":"9745_CR107","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1128\/MCB.24.1.164-171.2003","volume":"24","author":"D Wang","year":"2004","unstructured":"Wang D, Matsumoto R, You Y, Che T, Lin XY, Gaffen SL et al (2004) CD3\/CD28 costimulation-induced NF-kappaB activation is mediated by recruitment of protein kinase C-theta, Bcl10, and IkappaB kinase beta to the immunological synapse through CARMA1. Mol Cell Biol 24(1):164\u2013171","journal-title":"Mol Cell Biol"},{"issue":"15","key":"9745_CR108","doi-asserted-by":"crossref","first-page":"11877","DOI":"10.1074\/jbc.M010512200","volume":"276","author":"J Bertin","year":"2001","unstructured":"Bertin J, Wang L, Guo Y, Jacobson MD, Poyet JL, Srinivasula SM et al (2001) CARD11 and CARD14 are novel caspase recruitment domain (CARD)\/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappa B. J Biol Chem 276(15):11877\u201311882","journal-title":"J Biol Chem"},{"issue":"24","key":"9745_CR109","doi-asserted-by":"crossref","first-page":"21405","DOI":"10.1074\/jbc.M102488200","volume":"276","author":"L Wang","year":"2001","unstructured":"Wang L, Guo Y, Huang WJ, Ke X, Poyet JL, Manji GA et al (2001) Card10 is a novel caspase recruitment domain\/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B. J Biol Chem 276(24):21405\u201321409","journal-title":"J Biol Chem"},{"issue":"52","key":"9745_CR110","doi-asserted-by":"crossref","first-page":"41082","DOI":"10.1074\/jbc.C000726200","volume":"275","author":"J Bertin","year":"2000","unstructured":"Bertin J, Guo Y, Wang L, Srinivasula SM, Jacobson MD, Poyet JL et al (2000) CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10\/CLAP and activates NF-kappa B. J Biol Chem 275(52):41082\u201341086","journal-title":"J Biol Chem"},{"issue":"2","key":"9745_CR111","doi-asserted-by":"crossref","first-page":"918","DOI":"10.4049\/jimmunol.181.2.918","volume":"181","author":"H Hara","year":"2008","unstructured":"Hara H, Ishihara C, Takeuchi A, Xue L, Morris SW, Penninger JM et al (2008) Cell type-specific regulation of ITAM-mediated NF-kappaB activation by the adaptors, CARMA1 and CARD9. J Immunol 181(2):918\u2013930","journal-title":"J Immunol"},{"issue":"10","key":"9745_CR112","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1158\/0008-5472.CAN-05-4590","volume":"66","author":"M Baens","year":"2006","unstructured":"Baens M, Fevery S, Sagaert X, Noels H, Hagens S, Broeckx V et al (2006) Selective expansion of marginal zone B cells in Emicro-API2-MALT1 mice is linked to enhanced IkappaB kinase gamma polyubiquitination. Cancer Res 66(10):5270\u20135277","journal-title":"Cancer Res"},{"issue":"16","key":"9745_CR113","doi-asserted-by":"crossref","first-page":"15870","DOI":"10.1074\/jbc.M310599200","volume":"279","author":"T Che","year":"2004","unstructured":"Che T, You Y, Wang D, Tanner MJ, Dixit VM, Lin X (2004) MALT1\/paracaspase is a signaling component downstream of CARMA1 and mediates T cell receptor-induced NF-kappaB activation. J Biol Chem 279(16):15870\u201315876","journal-title":"J Biol Chem"},{"key":"9745_CR114","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1034\/j.1600-065X.2003.00049.x","volume":"193","author":"J Ruland","year":"2003","unstructured":"Ruland J, Mak TW (2003) Transducing signals from antigen receptors to nuclear factor kappaB. Immunol Rev 193:93\u2013100","journal-title":"Immunol Rev"},{"issue":"24","key":"9745_CR115","doi-asserted-by":"crossref","first-page":"12829","DOI":"10.1073\/pnas.94.24.12829","volume":"94","author":"J Huang","year":"1997","unstructured":"Huang J, Gao X, Li S, Cao Z (1997) Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc Natl Acad Sci USA 94(24):12829\u201312832","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"9745_CR116","doi-asserted-by":"crossref","first-page":"13757","DOI":"10.1074\/jbc.270.23.13757","volume":"270","author":"SA Greenfeder","year":"1995","unstructured":"Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G (1995) Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem 270(23):13757\u201313765","journal-title":"J Biol Chem"},{"issue":"6","key":"9745_CR117","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1074-7613(00)80402-1","volume":"7","author":"H Wesche","year":"1997","unstructured":"Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z (1997) MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7(6):837\u2013847","journal-title":"Immunity"},{"issue":"5252","key":"9745_CR118","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1126\/science.271.5252.1128","volume":"271","author":"Z Cao","year":"1996","unstructured":"Cao Z, Henzel WJ, Gao X (1996) IRAK: a kinase associated with the interleukin-1 receptor. Science 271(5252):1128\u20131131","journal-title":"Science"},{"issue":"6","key":"9745_CR119","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/35014038","volume":"2","author":"K Burns","year":"2000","unstructured":"Burns K, Clatworthy J, Martin L, Martinon F, Plumpton C, Maschera B et al (2000) Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat Cell Biol 2(6):346\u2013351","journal-title":"Nat Cell Biol"},{"issue":"10","key":"9745_CR120","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S1471-4906(02)02298-6","volume":"23","author":"N Suzuki","year":"2002","unstructured":"Suzuki N, Suzuki S, Yeh WC (2002) IRAK-4 as the central TIR signaling mediator in innate immunity. Trends Immunol 23(10):503\u2013506","journal-title":"Trends Immunol"},{"issue":"7","key":"9745_CR121","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1074\/jbc.M309251200","volume":"279","author":"C Kollewe","year":"2004","unstructured":"Kollewe C, Mackensen AC, Neumann D, Knop J, Cao P, Li S et al (2004) Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling. J Biol Chem 279(7):5227\u20135236","journal-title":"J Biol Chem"},{"issue":"20","key":"9745_CR122","doi-asserted-by":"crossref","first-page":"7158","DOI":"10.1128\/MCB.22.20.7158-7167.2002","volume":"22","author":"Z Jiang","year":"2002","unstructured":"Jiang Z, Ninomiya-Tsuji J, Qian Y, Matsumoto K, Li X (2002) Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB 2 at the plasma membrane and activate TAK1 in the cytosol. Mol Cell Biol 22(20):7158\u20137167","journal-title":"Mol Cell Biol"},{"issue":"13","key":"9745_CR123","doi-asserted-by":"crossref","first-page":"10952","DOI":"10.1074\/jbc.M212112200","volume":"278","author":"Z Jiang","year":"2003","unstructured":"Jiang Z, Johnson HJ, Nie H, Qin J, Bird TA, Li X (2003) Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J Biol Chem 278(13):10952\u201310956","journal-title":"J Biol Chem"},{"issue":"3","key":"9745_CR124","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.4049\/jimmunol.171.3.1500","volume":"171","author":"LE Jensen","year":"2003","unstructured":"Jensen LE, Whitehead AS (2003) Pellino3, a novel member of the Pellino protein family, promotes activation of c-Jun and Elk-1 and may act as a scaffolding protein. J Immunol 171(3):1500\u20131506","journal-title":"J Immunol"},{"issue":"2\u20133","key":"9745_CR125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-5793(03)00533-7","volume":"545","author":"LE Jensen","year":"2003","unstructured":"Jensen LE, Whitehead AS (2003) Pellino2 activates the mitogen activated protein kinase pathway. FEBS Lett 545(2\u20133):199\u2013202","journal-title":"FEBS Lett"},{"key":"9745_CR126","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","volume":"20","author":"CA Janeway Jr","year":"2002","unstructured":"Janeway CA Jr, Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197\u2013216","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"9745_CR127","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ni886","volume":"4","author":"H Oshiumi","year":"2003","unstructured":"Oshiumi H, Matsumoto M, Funami K, Akazawa T, Seya T (2003) TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 4(2):161\u2013167","journal-title":"Nat Immunol"},{"issue":"2","key":"9745_CR128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.onc.1210907","volume":"27","author":"R Chen","year":"2008","unstructured":"Chen R, Alvero AB, Silasi DA, Steffensen KD, Mor G (2008) Cancers take their Toll\u2014the function and regulation of Toll-like receptors in cancer cells. Oncogene 27(2):225\u2013233","journal-title":"Oncogene"},{"issue":"5625","key":"9745_CR129","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1126\/science.1085536","volume":"300","author":"GM Barton","year":"2003","unstructured":"Barton GM, Medzhitov R (2003) Toll-like receptor signaling pathways. Science 300(5625):1524\u20131525","journal-title":"Science"},{"issue":"18","key":"9745_CR130","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1073\/pnas.94.18.9792","volume":"94","author":"HY Song","year":"1997","unstructured":"Song HY, Regnier CH, Kirschning CJ, Goeddel DV, Rothe M (1997) Tumor necrosis factor (TNF)-mediated kinase cascades: bifurcation of nuclear factor-kappaB and c-jun N-terminal kinase (JNK\/SAPK) pathways at TNF receptor-associated factor 2. Proc Natl Acad Sci USA 94(18):9792\u20139796","journal-title":"Proc Natl Acad Sci USA"},{"issue":"44","key":"9745_CR131","doi-asserted-by":"crossref","first-page":"6482","DOI":"10.1038\/sj.onc.1204788","volume":"20","author":"JR Bradley","year":"2001","unstructured":"Bradley JR, Pober JS (2001) Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20(44):6482\u20136491","journal-title":"Oncogene"},{"issue":"9","key":"9745_CR132","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/ncb1296","volume":"7","author":"V Tergaonkar","year":"2005","unstructured":"Tergaonkar V, Correa RG, Ikawa M, Verma IM (2005) Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. Nat Cell Biol 7(9):921\u2013923","journal-title":"Nat Cell Biol"},{"issue":"38","key":"9745_CR133","doi-asserted-by":"crossref","first-page":"29840","DOI":"10.1074\/jbc.M004899200","volume":"275","author":"CB Phelps","year":"2000","unstructured":"Phelps CB, Sengchanthalangsy LL, Huxford T, Ghosh G (2000) Mechanism of I kappa B alpha binding to NF-kappa B dimers. J Biol Chem 275(38):29840\u201329846","journal-title":"J Biol Chem"},{"issue":"6","key":"9745_CR134","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1128\/MCB.20.6.2269-2284.2000","volume":"20","author":"WF Tam","year":"2000","unstructured":"Tam WF, Lee LH, Davis L, Sen R (2000) Cytoplasmic sequestration of rel proteins by IkappaBalpha requires CRM1-dependent nuclear export. Mol Cell Biol 20(6):2269\u20132284","journal-title":"Mol Cell Biol"},{"issue":"11","key":"9745_CR135","doi-asserted-by":"crossref","first-page":"7701","DOI":"10.1074\/jbc.C000916200","volume":"276","author":"WF Tam","year":"2001","unstructured":"Tam WF, Sen R (2001) IkappaB family members function by different mechanisms. J Biol Chem 276(11):7701\u20137704","journal-title":"J Biol Chem"},{"issue":"2","key":"9745_CR136","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ncb1086","volume":"6","author":"T Bouwmeester","year":"2004","unstructured":"Bouwmeester T, Bauch A, Ruffner H, Angrand PO, Bergamini G, Croughton K et al (2004) A physical and functional map of the human TNF-alpha\/NF-kappa B signal transduction pathway. Nat Cell Biol 6(2):97\u2013105","journal-title":"Nat Cell Biol"},{"issue":"11","key":"9745_CR137","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.4161\/cc.6.11.4312","volume":"6","author":"HC Thoms","year":"2007","unstructured":"Thoms HC, Dunlop MG, Stark LA (2007) CDK4 inhibitors and apoptosis: a novel mechanism requiring nucleolar targeting of RelA. Cell Cycle 6(11):1293\u20131297","journal-title":"Cell Cycle"},{"issue":"33","key":"9745_CR138","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1038\/sj.onc.1210271","volume":"26","author":"S Fan","year":"2007","unstructured":"Fan S, Meng Q, Laterra JJ, Rosen EM (2007) Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage. Oncogene 26(33):4774\u20134796","journal-title":"Oncogene"},{"issue":"1","key":"9745_CR139","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ni0102-20","volume":"3","author":"Y Ben-Neriah","year":"2002","unstructured":"Ben-Neriah Y (2002) Regulatory functions of ubiquitination in the immune system. Nat Immunol 3(1):20\u201326","journal-title":"Nat Immunol"},{"key":"9745_CR140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","volume":"18","author":"M Karin","year":"2000","unstructured":"Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18:621\u2013663","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"9745_CR141","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1101\/gad.13.3.284","volume":"13","author":"E Spencer","year":"1999","unstructured":"Spencer E, Jiang J, Chen ZJ (1999) Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb\/beta-TrCP. Genes Dev 13(3):284\u2013294","journal-title":"Genes Dev"},{"issue":"3","key":"9745_CR142","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1101\/gad.13.3.270","volume":"13","author":"JT Winston","year":"1999","unstructured":"Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ, Harper JW (1999) The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev 13(3):270\u2013283","journal-title":"Genes Dev"},{"issue":"5","key":"9745_CR143","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0092-8674(00)00080-5","volume":"102","author":"T Hoppe","year":"2000","unstructured":"Hoppe T, Matuschewski K, Rape M, Schlenker S, Ulrich HD, Jentsch S (2000) Activation of a membrane-bound transcription factor by regulated ubiquitin\/proteasome-dependent processing. Cell 102(5):577\u2013586","journal-title":"Cell"},{"issue":"4","key":"9745_CR144","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0092-8674(89)90578-3","volume":"56","author":"S Buratowski","year":"1989","unstructured":"Buratowski S, Hahn S, Guarente L, Sharp PA (1989) Five intermediate complexes in transcription initiation by RNA polymerase II. Cell 56(4):549\u2013561","journal-title":"Cell"},{"issue":"4","key":"9745_CR145","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.emboj.7600111","volume":"23","author":"C Leurent","year":"2004","unstructured":"Leurent C, Sanders SL, Demeny MA, Garbett KA, Ruhlmann C, Weil PA et al (2004) Mapping key functional sites within yeast TFIID. EMBO J 23(4):719\u2013727","journal-title":"EMBO J"},{"issue":"6","key":"9745_CR146","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/emboj\/cdg139","volume":"22","author":"L Vermeulen","year":"2003","unstructured":"Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G (2003) Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1). EMBO J 22(6):1313\u20131324","journal-title":"EMBO J"},{"issue":"1","key":"9745_CR147","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tibs.2004.11.009","volume":"30","author":"P Viatour","year":"2005","unstructured":"Viatour P, Merville MP, Bours V, Chariot A (2005) Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem Sci 30(1):43\u201352","journal-title":"Trends Biochem Sci"},{"issue":"16","key":"9745_CR148","doi-asserted-by":"crossref","first-page":"13395","DOI":"10.1074\/jbc.M011176200","volume":"276","author":"H Uranishi","year":"2001","unstructured":"Uranishi H, Tetsuka T, Yamashita M, Asamitsu K, Shimizu M, Itoh M et al (2001) Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator. J Biol Chem 276(16):13395\u201313401","journal-title":"J Biol Chem"},{"issue":"1","key":"9745_CR149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevOncog.v15.i1-2.10","volume":"15","author":"H Reikvam","year":"2009","unstructured":"Reikvam H, Olsnes AM, Gjertsen BT, Ersvar E, Bruserud O (2009) Nuclear factor-kappaB signaling: a contributor in leukemogenesis and a target for pharmacological intervention in human acute myelogenous leukemia. Crit Rev Oncog 15(1):1\u201336","journal-title":"Crit Rev Oncog"},{"issue":"2","key":"9745_CR150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mc.20606","volume":"49","author":"JC Lauscher","year":"2010","unstructured":"Lauscher JC, Gr\u00f6ne J, Dullat S, Hotz B, Ritz JP, Steinhoff U et al (2010) Association between activation of atypical NF-\u03baB1 p105 signaling pathway and nuclear \u03b2-catenin accumulation in colorectal carcinoma. Mol Carcinog 49(2):121\u2013129","journal-title":"Mol Carcinog"},{"issue":"1","key":"9745_CR151","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1158\/1541-7786.MCR-09-0277","volume":"8","author":"A Zoubeidi","year":"2010","unstructured":"Zoubeidi A, Ettinger S, Beraldi E, Hadaschik B, Zardan A, Klomp LWJ et al (2010) Clusterin Facilitates COMMD1 and I-\u00ce\u00baB Degradation to Enhance NF-\u00ce\u00baB Activity in Prostate Cancer Cells. Molecular Cancer Research 8(1):119\u2013130","journal-title":"Molecular Cancer Research"},{"issue":"6","key":"9745_CR152","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1096\/fj.09-138305","volume":"24","author":"R Nehra","year":"2010","unstructured":"Nehra R, Riggins RB, Shajahan AN, Zwart A, Crawford AC, Clarke R (2010) BCL2 and CASP8 regulation by NF-{kappa}B differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells. Faseb J 24(6):2040\u20132055","journal-title":"Faseb J"},{"issue":"2","key":"9745_CR153","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.311","volume":"41","author":"RP Nair","year":"2009","unstructured":"Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D et al (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-[kappa]B pathways. Nat Genet 41(2):199\u2013204","journal-title":"Nat Genet"},{"issue":"6","key":"9745_CR154","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.placenta.2008.02.008","volume":"29","author":"C Escudero","year":"2008","unstructured":"Escudero C, Sobrevia L (2008) A hypothesis for preeclampsia: adenosine and inducible nitric oxide synthase in human placental microvascular endothelium. Placenta 29(6):469\u2013483","journal-title":"Placenta"},{"issue":"2","key":"9745_CR155","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1152\/physrev.00040.2009","volume":"90","author":"N Bakkar","year":"2010","unstructured":"Bakkar N, Guttridge DC (2010) NF-kappaB signaling: a tale of two pathways in skeletal myogenesis. Physiol Rev 90(2):495\u2013511","journal-title":"Physiol Rev"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-011-9745-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-011-9745-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-011-9745-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T15:25:29Z","timestamp":1712244329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-011-9745-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,27]]},"references-count":155,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["9745"],"URL":"https:\/\/doi.org\/10.1007\/s10552-011-9745-4","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,27]]}}}